Erez Aminov Biography and Net Worth

Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for neuropsychiatric disorders. Under his leadership, MIRA is advancing transformative therapies such as MIRA55 and Ketamir-2, aiming to address critical unmet medical needs with safe and effective solutions.

With a deep expertise in biotechnology consulting, investment, and leadership, Mr. Aminov has played a pivotal role in shaping the biopharma landscape. Prior to joining MIRA, he founded Locate Venture Corp, where he supported early-stage biotech enterprises and fostered growth through strategic partnerships. He has also served as a trusted consultant for multiple biotech firms and successfully guided two companies through IPOs on the Nasdaq, showcasing his ability to navigate complex financial and regulatory environments.

At MIRA, Mr. Aminov has been instrumental in securing funding, licensing proprietary technologies, and overseeing the submission of Investigational New Drug (IND) applications. His strategic vision continues to position MIRA for success, with pivotal preclinical studies paving the way for clinical advancements.

In addition, Mr. Aminov serves as the Chairman and Chief Executive Officer of Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a biotechnology company dedicated to developing Telomir-1, an innovative therapeutic targeting telomere elongation and protection to treat age- related inflammatory and degenerative conditions.

Mr. Aminov holds a Bachelor of Arts in Accounting from Touro University in New York. His unique blend of financial acumen and forward-thinking leadership drives his mission to advance groundbreaking therapies and deliver value to stakeholders.

What is Erez Aminov's net worth?: The estimated net worth of Erez Aminov is at least $980.84 thousand as of November 19th, 2024. Aminov owns 1,105,790 shares of MIRA Pharmaceuticals stock worth more than $980,836 as of September 25th. This net worth evaluation does not reflect any other assets that Aminov may own. Learn More about Erez Aminov's net worth.
How do I contact Erez Aminov?: The corporate mailing address for Aminov and other MIRA Pharmaceuticals executives is 1200 Brickell Avenue, Suite 1950 #1183, Miami, FL, 33131. MIRA Pharmaceuticals can also be reached via phone at (813) 369-5150 and via email at [email protected]. Learn More on Erez Aminov's contact information.
Has Erez Aminov been buying or selling shares of MIRA Pharmaceuticals?: Erez Aminov has not been actively trading shares of MIRA Pharmaceuticals in the last ninety days. Most recently, Erez Aminov sold 55,410 shares of the business's stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $1.39, for a transaction totalling $77,019.90. Following the completion of the sale, the chief executive officer now directly owns 1,105,790 shares of the company's stock, valued at $1,537,048.10. Learn More on Erez Aminov's trading history.

Erez Aminov Insider Trading History at MIRA Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/19/2024	Sell	55,410	$1.39	$77,019.90	1,105,790
5/21/2024	Buy	8,700	$0.94	$8,178.00	382,200

Erez Aminov Buying and Selling Activity at MIRA Pharmaceuticals

MIRA Pharmaceuticals Company Overview

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Today's Range

Now: $0.89

$0.85

$0.89

50 Day Range

MA: $0.79

$0.61

$0.96

2 Week Range

Now: $0.89

$0.60

$2.45

Volume

76,719 shs

Average Volume

293,340 shs

Market Capitalization

$37.27 million

P/E Ratio

N/A

Dividend Yield